Altimmune (ALT) Non-Current Assets (2010 - 2026)

Altimmune (ALT) has 17 years of Non-Current Assets data on file, last reported at $954000.0 in Q1 2026.

• Non-Current Assets for Q1 2026 came in at $954000.0, down 52.32% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.5 million (down 22.45% YoY), and the FY2025 annual result was $1.7 million, down 15.35% from the prior year.
• Non-Current Assets retreated to $954000.0 in Q1 2026 per ALT's latest filing, from $1.7 million in the prior quarter.
• Over five years, Non-Current Assets peaked at $14.6 million in Q1 2022 and troughed at $843000.0 in Q1 2024.
• A 5-year average of $6.8 million and a median of $2.1 million in 2024 frame the typical range for Non-Current Assets.
• The sharpest annual moves came in 2024 and 2025: Non-Current Assets tumbled 93.97% in 2024, then surged 137.37% in 2025.
• A 5-year view of Non-Current Assets shows it stood at $14.1 million in 2022, then tumbled by 92.82% to $1.0 million in 2023, then surged by 102.37% to $2.1 million in 2024, then decreased by 15.35% to $1.7 million in 2025, then slumped by 45.08% to $954000.0 in 2026.
• Business Quant data shows ALT's Non-Current Assets at $954000.0 in Q1 2026, $1.7 million in Q4 2025, and $1.8 million in Q3 2025.